From Nepal to the world, JSI's pioneering program to scale up use of chlorhexidine, a life-saving antiseptic

In developing countries, 28% of newborn deaths are due to infections.1 The entry point for many of these infections is the umbilical cord. High rates of home delivery, unhygienic cord care practices (e.g., use of unsterilized cutting instruments and application of potentially harmful substances), and poor infection prevention practices in health facilities all contribute to newborn infection and mortality.

JSI has been at the forefront of global efforts to prevent newborn infections through introduction of chlorhexidine, a simple antiseptic, applied to the freshly cut umbilical cord stump.

Learn more about JSI's work:

In recognition of the global influence of the CHX life-saving program in Nepal, USAID awarded JSI a Pioneer Prize for Science and Technology in 2013. Leela Khanal, JSI's program director in Nepal, has traveled the globe to share our work and inspire others. Funders for our CHX work include the Bill & Melinda Gates Foundation, USAID, the Government of Norway, Grand Challenges Canada, DFID, and UNFPA. JSI is an active member of the global chlorhexidine working group, chaired by PATH.

1. Lawn JE, Cousens SD, and Zupan J (2005). "4 million neonatal deaths: When? Where? Why?" The Lancet. 365(9462):891-900. DOI: 10.1016/S0140-6736(05)71048-5e31816791a2